Effects of platforms, size filter cutoffs, and targeted regions of cytogenomic microarray on detection of copy number variants and uniparental disomy in prenatal diagnosis: Results from 5026 pregnancies.


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
02 2019
Historique:
received: 22 02 2018
revised: 02 10 2018
accepted: 10 10 2018
pubmed: 9 2 2019
medline: 18 12 2019
entrez: 9 2 2019
Statut: ppublish

Résumé

We evaluated the effects of platforms, size filter cutoffs, and targeted regions of cytogenomic microarray (CMA) on the detection of copy number variants (CNVs) and uniparental disomy (UPD) in prenatal diagnosis. Five thousand twenty-six consecutive prenatal specimens (>98% high-risk pregnancy) were studied by high-resolution CMA, with cutoffs of 50 kb for losses and 200 kb for gains in nontargeted regions and 20 kb for losses and 100 kb for gains in targeted regions. We assessed actual detection rates using the current assay as well as hypothetical detection rates using platforms with the same or lower resolution and smaller or larger cutoffs. The detection rate of our current assay was 11.2% (562 of 5026), including abnormal findings in 543 cases and likely pathogenic variants in 19. The hypothetical decrease in the overall detection of variants (excluding likely benign) and UPD ranged from 3.8% to 23.0%. For the subgroup of pathogenic and likely pathogenic CNVs < 1 Mb, the decrease of detection ranged from 2.7% to 24.3%. These findings underscore the significant effects of chosen CMA platform, as well as size filter cutoffs and targeted regions used in data analysis, on detection of CNVs and UPDs in a cohort of prenatal cases.

Identifiants

pubmed: 30734327
doi: 10.1002/pd.5375
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

137-156

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Jia-Chi Wang (JC)

Cytogenetics and Genomics, Quest Diagnostics Nichols Institute, San Juan Capistrano, California.

Jeff Radcliff (J)

Cytogenetics and Genomics, Quest Diagnostics Nichols Institute, San Juan Capistrano, California.

Sandra J Coe (SJ)

Cytogenetics and Genomics, Quest Diagnostics Nichols Institute, San Juan Capistrano, California.

Loretta W Mahon (LW)

Cytogenetics and Genomics, Quest Diagnostics Nichols Institute, San Juan Capistrano, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH